DrugCite
Search

LACOSAMIDE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Lacosamide Adverse Events Reported to the FDA Over Time

How are Lacosamide adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lacosamide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lacosamide is flagged as the suspect drug causing the adverse event.

Most Common Lacosamide Adverse Events Reported to the FDA

What are the most common Lacosamide adverse events reported to the FDA?

Convulsion
323 (6.31%)
Dizziness
126 (2.46%)
Diplopia
104 (2.03%)
Grand Mal Convulsion
84 (1.64%)
Status Epilepticus
82 (1.6%)
Fatigue
70 (1.37%)
Vomiting
64 (1.25%)
Nausea
62 (1.21%)
Drug Ineffective
61 (1.19%)
Somnolence
58 (1.13%)
Gait Disturbance
52 (1.02%)
Show More Show More
Headache
52 (1.02%)
Vision Blurred
52 (1.02%)
Balance Disorder
50 (.98%)
Drug Interaction
49 (.96%)
Fall
47 (.92%)
Condition Aggravated
46 (.9%)
Depression
45 (.88%)
Off Label Use
44 (.86%)
Suicidal Ideation
44 (.86%)
Aggression
41 (.8%)
Weight Increased
38 (.74%)
Ataxia
37 (.72%)
Rash
37 (.72%)
Abnormal Behaviour
36 (.7%)
Tremor
34 (.66%)
Neurotoxicity
32 (.62%)
Death
30 (.59%)
Bradycardia
29 (.57%)
Epilepsy
29 (.57%)
Pregnancy
28 (.55%)
Diarrhoea
27 (.53%)
Syncope
27 (.53%)
Agitation
26 (.51%)
Chest Pain
26 (.51%)
Psychotic Disorder
26 (.51%)
Feeling Abnormal
25 (.49%)
Pneumonia
25 (.49%)
Partial Seizures
24 (.47%)
Drug Exposure During Pregnancy
23 (.45%)
Anxiety
22 (.43%)
Pruritus
22 (.43%)
Atrial Fibrillation
21 (.41%)
Confusional State
21 (.41%)
Dyspnoea
21 (.41%)
Memory Impairment
21 (.41%)
Road Traffic Accident
21 (.41%)
Amnesia
20 (.39%)
Dysphagia
19 (.37%)
Asthenia
18 (.35%)
Blood Glucose Increased
18 (.35%)
Encephalopathy
18 (.35%)
Hallucination
18 (.35%)
Alopecia
17 (.33%)
Complex Partial Seizures
17 (.33%)
Irritability
17 (.33%)
No Therapeutic Response
17 (.33%)
Oedema Peripheral
17 (.33%)
Abdominal Pain
16 (.31%)
Blood Pressure Increased
16 (.31%)
Hyponatraemia
16 (.31%)
Lethargy
16 (.31%)
Loss Of Consciousness
16 (.31%)
Pollakiuria
16 (.31%)
Anticonvulsant Drug Level Decreased
15 (.29%)
Concussion
15 (.29%)
Crying
15 (.29%)
Pyrexia
15 (.29%)
Suicide Attempt
15 (.29%)
Tonsillitis
15 (.29%)
Urinary Tract Infection
15 (.29%)
Vertigo
15 (.29%)
Weight Decreased
15 (.29%)
White Blood Cell Count Decreased
15 (.29%)
Contusion
14 (.27%)
Disorientation
14 (.27%)
Dyskinesia
14 (.27%)
Electrocardiogram Pr Prolongation
14 (.27%)
Febrile Neutropenia
14 (.27%)
Insomnia
14 (.27%)
Palpitations
14 (.27%)
Tachycardia
14 (.27%)
Cardiac Arrest
13 (.25%)
Chest Discomfort
13 (.25%)
Coma
13 (.25%)
Decreased Appetite
13 (.25%)
Dysarthria
13 (.25%)
Hyperhidrosis
13 (.25%)
No Adverse Event
13 (.25%)
Petit Mal Epilepsy
13 (.25%)
Sedation
13 (.25%)
Abasia
12 (.23%)
Caesarean Section
12 (.23%)
Cognitive Disorder
12 (.23%)
General Physical Health Deteriorati...
12 (.23%)
Head Injury
12 (.23%)
Hypotension
12 (.23%)
Leukopenia
12 (.23%)
Malaise
12 (.23%)
Medication Error
12 (.23%)
Pain
12 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Lacosamide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lacosamide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lacosamide

What are the most common Lacosamide adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lacosamide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lacosamide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Lacosamide According to Those Reporting Adverse Events

Why are people taking Lacosamide, according to those reporting adverse events to the FDA?

Convulsion
448
Epilepsy
437
Partial Seizures
98
Status Epilepticus
53
Complex Partial Seizures
38
Product Used For Unknown Indication
19
Show More Show More
Diabetic Neuropathy
12
Grand Mal Convulsion
11
Idiopathic Generalised Epilepsy
8
Drug Use For Unknown Indication
6
Headache
5
Neuralgia
4
Off Label Use
4
Frontal Lobe Epilepsy
4
Overdose
4
Optic Neuropathy
3
Petit Mal Epilepsy
3
Drop Attacks
2
Simple Partial Seizures
2
Trigeminal Neuralgia
2
Migraine
2
Myoclonic Epilepsy
2
Pain
2
Facial Pain
2
Lennox-gastaut Syndrome
2
Lethargy
2
Limb Discomfort
1
Dyskinesia
1
Encephalopathy
1
Juvenile Myoclonic Epilepsy
1
Glioblastoma
1
Unevaluable Event
1
Psychotic Disorder
1
Cluster Headache
1
Porphyria
1
Pain In Extremity
1
Melas Syndrome
1
Sturge-weber Syndrome
1
Temporal Lobe Epilepsy
1
Drug Withdrawal Convulsions
1
Partial Seizures With Secondary Gen...
1

Drug Labels

LabelLabelerEffective
VimpatPhysicians Total Care, Inc.12-JAN-12
VimpatKremers Urban Pharmaceuticals Inc23-OCT-12

Lacosamide Case Reports

What Lacosamide safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Lacosamide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Lacosamide.